Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Net loss - before noncontrolling interest	$ (22,214)	$ (19,633)
Net loss attributable to noncontrolling interest	4,283	2,761
Net loss - as reported, attributable to PAVmed Inc.	(17,931)	(16,872)
Series B Convertible Preferred Stock dividends – earned	(74)	(68)
Net loss attributable to PAVmed Inc. common stockholders	$ (18,005)	$ (16,940)
Weighted average common shares outstanding, basic and diluted	97,095,156	86,336,427
Net loss - as reported, attributable to PAVmed Inc.	$ (0.18)	$ (0.20)
Net loss attributable to PAVmed Inc. common stockholders	$ (0.19)	$ (0.20)